uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Regeneron Keeps Science at the Center January 16, 2018 Invacare Proposes $100 Million Raise June 8, 2017 Biogen Buys Pfizer's PhII-ready Schizophrenia Asset March 11, 2018
